Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 20 of 45 for “"SF3B1"”.

  1. Dissecting the role of CDK8 mis-splicing in SF3B1-mutant MDS

    Somatic SF3B1 mutations are believed to arise early in the pathogenesis of clonal myeloid disorders such as myelodysplastic syndromes (MDS). Studies show that SF3B1 mutations bias hematopoietic stem and progenitor cells (HSPCs) toward the myeloid and erythroid lineages and impair terminal erythroid …

    washington Repository record for Dissecting the role of CDK8 mis-splicing in SF3B1-mutant MDS (opens in a new tab)

  2. Dissecting the role of aberrant splicing in mutant-SF3B1 myelodysplastic syndromes

    … occur within the core U2 spliceosome factors SF3B1, U2AF1, and SRSF2. One common MDS subtype, MDS with ring sideroblasts (MDS-RS) is highly correlated with heterozygous gain-of-function mutations in SF3B1, which occur in ~80% of these patients. This subtype is characterized by ineffective …

    washington Repository record for Dissecting the role of aberrant splicing in mutant-SF3B1 myelodysplastic syndromes (opens in a new tab)

  3. THE ROLE OF SPLICING FACTOR SF3B1 IN TRANSCRIPTIONAL AND EPIGENETIC REGULATION

    … revealed in this screen was the splicing factor SF3B1. SF3B1 is a well-known crucial splicing factor and is mutated in several cancers. However, its role in epigenetic regulation has not been well studied. I propose SF3B1 is a novel target for epigenetic therapy in cancer. In the YB5 colon cancer …

    temple Repository record for THE ROLE OF SPLICING FACTOR SF3B1 IN TRANSCRIPTIONAL AND EPIGENETIC REGULATION (opens in a new tab)

  4. Precursor RNA Properties Driving Cryptic 3’ Splice Site Selection in SF3B1 Mutant Malignancies

    SF3B1 is a core component of the spliceosome involved in branch point recognition and 3’ splice site selection. SF3B1 is commonly mutated in myelodysplastic syndromes and other blood cancers with the K700E mutation being the most frequent. This mutation of SF3B1 induces cryptic 3’ splice site …

    clemson Repository record for Precursor RNA Properties Driving Cryptic 3’ Splice Site Selection in SF3B1 Mutant Malignancies (opens in a new tab)

  5. UNDERSTANDING THE MOLECULAR BASIS OF SPLICE SITE SELECTION AND CANCER RELATED MUTATIONS IN SPLICING FACTOR PRP10/ SF3B1

    … ~200,000 introns encoded in the human genome. SF3B1 is an integral component of the spliceosome and known to play a role in activating the cognate branch point adenosine that later acts in the first chemical reaction of splicing. SF3B1 is also the most frequently mutated splicing factor found …

    cornell Repository record for UNDERSTANDING THE MOLECULAR BASIS OF SPLICE SITE SELECTION AND CANCER RELATED MUTATIONS IN SPLICING FACTOR PRP10/ SF3B1 (opens in a new tab)

  6. Interactions between splicing and transcription factors

    … The inhibition of an RNA processing factor, SF3B1, a component of the U2 small nuclear ribonucleoprotein (U2 snRNP) implicated in pre-mRNA splicing, by Pladienolide B (PlaB), also causes pol II to pause at the early-elongation checkpoint by reducing CDK9 recruitment. However, the underlying …

    oxford Repository record for Interactions between splicing and transcription factors (opens in a new tab)

  7. Mechanistic consequences of splicing factor mutations and their use for targeted cancer therapy

    … The most commonly mutated splicing factors are SF3B1 and SRSF2. While we know that mutations in each have distinct consequences on splicing, the molecular drivers of disease and sequence characteristics which influence mutant promoted alternative splicing remain unknown. To address this, I first …

    washington Repository record for Mechanistic consequences of splicing factor mutations and their use for targeted cancer therapy (opens in a new tab)

  8. Mechanisms of disease transformation in myeloproliferative neoplasms

    … I observed increased <i>TP53</i> and <i>SF3B1</i> mutations in patients with myelofibrotic progression which importantly was not alleviated with ruxolitinib treatment. Analysis of a second, more advanced myeloproliferative neoplasm cohort of ruxolitinib-resistant/intolerant myelofibrosis …

    oxford Repository record for Mechanisms of disease transformation in myeloproliferative neoplasms (opens in a new tab)

  9. Unravelling the molecular pathogenesis of Myelodysplastic Syndrome Patients with Ringed Sideroblasts

    … particular gene, splicing factor 3b subunit 1 (SF3B1), a component of the major and minor spliceosomes, in 11/12 cases. No SF3B1 mutations were observed in a single case of congenital sideroblastic anaemia, however, a constitutional mutation in ALAS1 gene was confirmed in this patient. …

    kings Repository record for Unravelling the molecular pathogenesis of Myelodysplastic Syndrome Patients with Ringed Sideroblasts (opens in a new tab) Download PDF for Unravelling the molecular pathogenesis of Myelodysplastic Syndrome Patients with Ringed Sideroblasts (opens in a new tab)

  10. Clinical and biological implications of genomic lesions in Chronic Lymphocytic Leukaemia

    … panel, identifying 903 variants (1.8/patient). SF3B1 was identified as the most recurrently mutated gene in the cohort (26%), with the mutation landscape and subclonal architecture assessed for all 25 genes, identifying previously observed and novel associations. Clinical statistical survival …

    soton Download PDF for Clinical and biological implications of genomic lesions in Chronic Lymphocytic Leukaemia (opens in a new tab)

  11. Development of analytical frameworks for the integration of molecular data views to understand the biology of myeloid malignancies

    … repertoire and chromatin profile of SF3B1-mutated Myelodysplastic Syndromes (MDS), leveraging bulk RNA and ATAC sequencing data from patient-derived genetically matched normal and SF3B1-mutated induced pluripotent stem cell (iPSC) lines. We introduce a multi-stage fusion framework …

    greece Repository record for Development of analytical frameworks for the integration of molecular data views to understand the biology of myeloid malignancies (opens in a new tab)

  12. The conserved role of RNA splicing factors in genome maintenance

    … progression, I studied five cancer-associated SF3B1 point mutations in the yeast ortholog HSH155. While the splicing activity in Hsh155 and SF3B1 were conserved, I did not observe measurable phenotypes in the yeast mutant strains. Thus, I used isogenic NALM6 human leukemia cell lines to …

    ubc Repository record for The conserved role of RNA splicing factors in genome maintenance (opens in a new tab) Download PDF for The conserved role of RNA splicing factors in genome maintenance (opens in a new tab)

  13. Caracterización histológica y molecular de una serie de casos de melanoma uveal primario con correlación clínica y pronóstica

    … secundarias más frecuentes se produjeron en SF3B1 (en el 26%), seguido de BAP1 (en el 23%), LRP1B (22%) y FGFR4 (20%). La mutación de BAP1 se asoció con una mayor probabilidad de metástasis y con una mayor presencia de células epitelioides. LRP1B también se asoció con la presencia de células …

    sevilla Repository record for Caracterización histológica y molecular de una serie de casos de melanoma uveal primario con correlación clínica y pronóstica (opens in a new tab)

  14. Immune consequences and therapeutic targeting of disrupted RNA splicing in cancer

    … mass cytometry-based approaches with leukemic SF3B1-mutant patient samples to characterize the immune environment in SF3B1-mutant cancers and search for antigen-specific T cells that recognize and respond to splicing-derived neoantigens.

    washington Repository record for Immune consequences and therapeutic targeting of disrupted RNA splicing in cancer (opens in a new tab)

  15. Spontaneously occurring clonal hematopoiesis in the canine

    … 12-15 years. Affected genes were ASXL1, KIT, SF3B1, TET2, RUNX1, and PPM1D. The variant in PPM1D was a nonsense mutation, while the other five variants were single nucleotide non-synonymous variants in protein coding regions of the genes. The single nucleotide variants in KIT and SF3B1 were …

    msu Repository record for Spontaneously occurring clonal hematopoiesis in the canine (opens in a new tab)

  16. Targeting SF3B1K700E in myeloid malignancy

    … machinery occur frequently in MDS, with SF3B1 representing the most commonly mutated splicing factor. The SF3B1K700E mutation promotes aberrant pre-mRNA splicing and altered transcript expression, potentially generating cellular dependencies that may be therapeutically …

    qu-belfast Repository record for Targeting SF3B1K700E in myeloid malignancy (opens in a new tab) Embargoed until 2031-12-31

  17. An investigation of the role of mutations in the spliceosome machinery in the myelodysplastic syndromes

    … Mutations in splicing factor genes (including SF3B1, SRSF2 and U2AF1) occur in over half of MDS patients and result in aberrant pre-mRNA splicing of many target genes, indicating that aberrant spliceosome function plays a key role in the pathogenesis of MDS. However, the molecular mechanisms …

    oxford Repository record for An investigation of the role of mutations in the spliceosome machinery in the myelodysplastic syndromes (opens in a new tab)

  18. Novel roles of the U2 splicing complex in antiviral defence

    … experiments. We also optimised iCLIP2 for SF3B1, SF1, U2AF2, and AQR to establish libraries for investigating their RNA-binding profiles during SINV infection. U2AF1 knockdown produced the strongest and most consistent increase in SINV titre, whereas SF1 knockdown showed a similar but …

    glasgow Repository record for Novel roles of the U2 splicing complex in antiviral defence (opens in a new tab) Download PDF for Novel roles of the U2 splicing complex in antiviral defence (opens in a new tab)

Page 1 of 3